Newsroom
Sorted by: Latest
-
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth Judicial Circuit in and for Palm Beach County, Florida, against SkinCure Oncology, LLC (SkinCure) alleging breach of contract related to unpaid amounts owed for Sensus pr...
-
Secretome Therapeutics Announces Participation in Upcoming Investor Conferences
PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel cellular and cell-based therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced its participation in three upcoming investor conferences and meetings focused on the biopharma sector. Secretome is scheduled to participate in Guggenheim Securities’ Healthcare Private Biopharma Company Virtual 1x1 Day on March 31, 2026, and Piper Sandler’s Spring Biopharma Sympos...
-
Millrose Properties Amends Credit Agreement, Expanding to a $1.835 Billon Unsecured Facility With the Addition of a $500 Million Term Loan Commitment
MIAMI--(BUSINESS WIRE)--Millrose Properties, Inc. (NYSE: MRP, "Millrose"), the leading homesite option platform for residential homebuilders, today announced the closing of an amendment to its credit facility with JPMorgan Chase Bank, N.A. serving as administrative agent, adding a new $500 million term loan to expand floating rate unsecured debt capacity under the facility to $1.835 billion. The amended unsecured facility, replacing the previously secured revolving credit facility, combines the...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 26.03.2026 FBTU.LN IE00BL0L0H60 500,002.00 USD 12,065,099.06 24.130 ...
-
RH Announces the Appointment of Veronica Schnitzius as President, Chief Manufacturing & Sourcing Officer
CORTE MADERA, Calif.--(BUSINESS WIRE)--RH (NYSE: RH) announced today that Veronica Schnitzius is joining the Company as President, Chief Manufacturing & Sourcing Officer. Veronica will lead RH’s efforts to build a global manufacturing platform that combines owned and operated, joint-ventured, and outsourced manufacturing for the Company’s core furniture business, which represents 80% of RH brand revenues. The strategy will emulate the vertically integrated model of many of the world’s large...
-
Intercontinental Exchange Announces New $600 Million Investment in Polymarket
ATLANTA & NEW YORK--(BUSINESS WIRE)--Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, today announced that, as part of its previously announced investment arrangement with Polymarket, ICE has completed a new $600 million direct cash investment in Polymarket, which is part of an equity capital fundraising by Polymarket. ICE also expects to make purchases of up to $40 million of Polymarket se...
-
Real Time Medical Systems to Demonstrate How Live Data Supports Clinical Standards and Survey Readiness at PALTC26
BALTIMORE--(BUSINESS WIRE)--Real Time Medical Systems (Real Time), the industry-leading, KLAS Rated, and HITRUST Certified post-acute analytics solution, announced today its participation in an additional educational session at PALTC26, the annual conference of the Post-Acute and Long-Term Care Medical Association (PALTmed), taking place March 26–28 in Anaheim, CA. As regulatory scrutiny intensifies alongside ongoing staffing challenges and rising clinical complexity, clinical and operational l...
-
Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's VTAMA (tapinarof) cream, 1% new Phase 3 pooled data analysis shows early and consistent skin clearance and itch improvements for AD patients...
-
Valérie Roberts devient la nouvelle égérie de Revlon ColorSilk au Québec
MONTRÉAL--(BUSINESS WIRE)--Revlon Canada choisit Valérie Roberts comme égérie pour ColorSilk au Québec, mettant en avant une coloration performante et adaptée au quotidien....
-
Senzing Launches Agentic Entity Resolution for Apache Spark
LAS VEGAS--(BUSINESS WIRE)--Senzing, an identity intelligence company, today announced the opening of its Senzing for Apache Spark beta program, bringing the company’s industry-leading entity resolution technology to distributed batch workloads for the first time. Organizations running Spark on AWS EMR, Databricks, or Snowflake can now resolve and relate billions of records across multiple data sources—from fully autonomous data profiling and preparation through to publishing the resolved entit...